Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

Stemline Therapeutics, Inc. (STML)

-NasdaqCM
15.68 Down 0.12(0.76%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:15.80
Open:15.70
Bid:14.85 x 400
Ask:22.20 x 100
1y Target Est:57.00
Beta:-4.709
Next Earnings Date:N/A
Day's Range:15.45 - 16.49
52wk Range:11.75 - 47.25
Volume:141,746
Avg Vol (3m):245,652
Market Cap:201.74M
P/E (ttm):N/A
EPS (ttm):-2.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for STML

Comparison

Symbol% ChgMkt Cap
STMLDown 0.76%201.74M
OMEDUp 3.96%766.19M
VSTMDown 2.09%229.56M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,863.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.16
Quarterly EPS Est (Mar-14) :-0.72
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary therapeutics for cancer stem cells and bulk tumors in the United States. View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback